Literature DB >> 17550134

Sentinel node biopsy in cutaneous melanoma: correlations between melanoma prognostic factors and sentinel node status.

E Minutilli1, D Giannarelli, M Anzà, R Garinei, P Perri, C Botti, L Piarulli, P Bruno, S Rea, R Visca, M Mottolese, S Di Filippo, F Di Filippo.   

Abstract

This study aims to correlate the most important prognostic factors of primary melanoma with sentinel node (SN) positive for metastases. We have enrolled 84 patients subjected to sentinel node biopsies for cutaneous melanomas of Breslow's thickness > or = 0.75 mm by using an intra-operative gamma probe after lymphoscintigraphy, without blue dye support. SN metastases were reported in 27% of cases (14% by histology and 13% by immunohistochemistry). By chi-square test Breslow's thickness > 2mm (p= 0.004), IV and V Clark's level (p= 0.02), ulceration (p= 0.05) and high mitotic rate (p= 0.05) were statistically significant (p < 0.05) with reference to SN positive for metastases, unlike the site of cutaneous melanoma, vertical growth phase, tumour infiltrating lymphocytes, regression and vascular invasion. Breslow's thickness remains the first prognostic factor to be considered for sentinel node biopsy in cutaneous melanoma, but other markers must be carefully estimated.

Entities:  

Mesh:

Year:  2007        PMID: 17550134

Source DB:  PubMed          Journal:  J Exp Clin Cancer Res        ISSN: 0392-9078


  3 in total

1.  Meta-analysis of sentinel lymph node positivity in thin melanoma (<or=1 mm).

Authors:  Melanie A Warycha; Jan Zakrzewski; Quanhong Ni; Richard L Shapiro; Russell S Berman; Anna C Pavlick; David Polsky; Madhu Mazumdar; Iman Osman
Journal:  Cancer       Date:  2009-02-15       Impact factor: 6.860

2.  Tumor-Infiltrating Lymphocytes in Patients with Melanoma: Which Is Its Prognostic Value?

Authors:  Cristian A Angeramo; Francisco Laxague; Enrique D Armella; Julieta Rodríguez Catán; Félix A Vigovich; Norberto A Mezzadri; Juan M Fernandez Vila
Journal:  Indian J Surg Oncol       Date:  2021-08-29

3.  Immunohistochemical expression of the glucose transporters Glut-1 and Glut-3 in human malignant melanomas and benign melanocytic lesions.

Authors:  Paola Parente; Antonella Coli; Guido Massi; Antonella Mangoni; Manuela M Fabrizi; Giulio Bigotti
Journal:  J Exp Clin Cancer Res       Date:  2008-09-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.